These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9635517)

  • 1. Inhibition of S-warfarin metabolism by nonsteroidal antiinflammatory drugs in human liver microsomes in vitro.
    Takigawa T; Tainaka H; Mihara K; Ogata H
    Biol Pharm Bull; 1998 May; 21(5):541-3. PubMed ID: 9635517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of omeprazole on the hydroxylation of warfarin enantiomers in human: in-vitro studies with liver microsomes and cDNA-expressed cytochrome P450 isozymes.
    Zhou Q; Zhou S; Chan E
    Curr Drug Metab; 2005 Oct; 6(5):399-411. PubMed ID: 16248835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monkey liver cytochrome P450 2C19 is involved in R- and S-warfarin 7-hydroxylation.
    Hosoi Y; Uno Y; Murayama N; Fujino H; Shukuya M; Iwasaki K; Shimizu M; Utoh M; Yamazaki H
    Biochem Pharmacol; 2012 Dec; 84(12):1691-5. PubMed ID: 23041648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance.
    Takahashi H; Kashima T; Kimura S; Murata N; Takaba T; Iwade K; Abe T; Tainaka H; Yasumori T; Echizen aH
    Drug Metab Dispos; 1999 Oct; 27(10):1179-86. PubMed ID: 10497145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ethanol on S-warfarin and diclofenac metabolism by recombinant human CYP2C9.1.
    Tatsumi A; Ikegami Y; Morii R; Sugiyama M; Kadobayashi M; Iwakawa S
    Biol Pharm Bull; 2009 Mar; 32(3):517-9. PubMed ID: 19252308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics.
    Hermans JJ; Thijssen HH
    Br J Pharmacol; 1993 Sep; 110(1):482-90. PubMed ID: 8220911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there differences in the catalytic activity per unit enzyme of recombinantly expressed and human liver microsomal cytochrome P450 2C9? A systematic investigation into inter-system extrapolation factors.
    Crewe HK; Barter ZE; Yeo KR; Rostami-Hodjegan A
    Biopharm Drug Dispos; 2011 Sep; 32(6):303-18. PubMed ID: 21725985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A major role for cytochrome P450TB (CYP2C subfamily) in the actions of non-steroidal antiinflammatory drugs.
    Leemann TD; Transon C; Bonnabry P; Dayer P
    Drugs Exp Clin Res; 1993; 19(5):189-95. PubMed ID: 8174491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.
    Kunze KL; Wienkers LC; Thummel KE; Trager WF
    Drug Metab Dispos; 1996 Apr; 24(4):414-21. PubMed ID: 8801056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9.
    He M; Korzekwa KR; Jones JP; Rettie AE; Trager WF
    Arch Biochem Biophys; 1999 Dec; 372(1):16-28. PubMed ID: 10562412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
    Turpeinen M; Hofmann U; Klein K; Mürdter T; Schwab M; Zanger UM
    Drug Metab Dispos; 2009 May; 37(5):1017-24. PubMed ID: 19204080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases.
    Malátková P; Sokolová S; Chocholoušová Havlíková L; Wsól V
    Biochem Pharmacol; 2016 Jun; 109():83-90. PubMed ID: 27055738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.
    Wienkers LC; Wurden CJ; Storch E; Kunze KL; Rettie AE; Trager WF
    Drug Metab Dispos; 1996 May; 24(5):610-4. PubMed ID: 8723744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers.
    Yamazaki H; Shimada T
    Biochem Pharmacol; 1997 Dec; 54(11):1195-203. PubMed ID: 9416970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
    Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1'-hydroxymethyleugenol.
    Jeurissen SM; Bogaards JJ; Boersma MG; ter Horst JP; Awad HM; Fiamegos YC; van Beek TA; Alink GM; Sudhölter EJ; Cnubben NH; Rietjens IM
    Chem Res Toxicol; 2006 Jan; 19(1):111-6. PubMed ID: 16411663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction.
    Fang ZZ; Zhang YY; Ge GB; Huo H; Liang SC; Yang L
    Br J Clin Pharmacol; 2010 Feb; 69(2):193-9. PubMed ID: 20233183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 species involved in the metabolism of quinoline.
    Reigh G; McMahon H; Ishizaki M; Ohara T; Shimane K; Esumi Y; Green C; Tyson C; Ninomiya S
    Carcinogenesis; 1996 Sep; 17(9):1989-96. PubMed ID: 8824525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of hepatic microsomal drug metabolism in rats by non-steroidal anti-inflammatory drugs.
    Gasperini R; Leone R; Velo GP; Fracasso ME
    Pharmacol Res; 1990; 22 Suppl 3():115-6. PubMed ID: 2097621
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.